Prathyusha Bagam
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Also affiliated: United States Food and Drug Administration (2022–2024); Southern University and Agricultural and Mechanical College (2016–2022)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Prathyusha Bagam's research investigates the molecular mechanisms underlying inflammatory responses and their connection to disease, particularly in the context of environmental exposures and cellular processes. Her work includes studies on the proteome and lipid profiles of membrane rafts in A549 cells exposed to e-cigarette vapor condensate, examining the impact on inflammatory responses. Bagam also investigates the role of pentachlorophenol in mediating the regulation of damage-associated molecular patterns (DAMPs) and inflammation in vitro. Her research extends to the application of induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) for predicting drug-induced cardiotoxicity, with a recent proof-of-concept study involving doxorubicin. Bagam has published 12 papers, with an h-index of 9 and 433 total citations. She has collaborated with researchers at the National Center for Toxicological Research, including Li Pang, Vikrant Vijay, William B. Mattes, and Katy S Papineau.
Metrics
- h-index: 9
- Publications: 12
- Citations: 462
Selected Publications
-
Predicting oncology drug-induced cardiotoxicity with donor-specific iPSC-CMs—a proof-of-concept study with doxorubicin (2024)
-
NADPH oxidase family proteins: signaling dynamics to disease management (2022)
-
Effects of Serum and Compound Preparation Methods on Delayed Repolarization Evaluation With Human iPSC-CMs (2022)
Collaboration Network
Top Collaborators
- Effects of Serum and Compound Preparation Methods on Delayed Repolarization Evaluation With Human iPSC-CMs
- Predicting oncology drug-induced cardiotoxicity with donor-specific iPSC-CMs—a proof-of-concept study with doxorubicin
- Effects of Serum and Compound Preparation Methods on Delayed Repolarization Evaluation With Human iPSC-CMs
- Effects of Serum and Compound Preparation Methods on Delayed Repolarization Evaluation With Human iPSC-CMs
- Effects of Serum and Compound Preparation Methods on Delayed Repolarization Evaluation With Human iPSC-CMs
- Effects of Serum and Compound Preparation Methods on Delayed Repolarization Evaluation With Human iPSC-CMs
- Effects of Serum and Compound Preparation Methods on Delayed Repolarization Evaluation With Human iPSC-CMs
- NADPH oxidase family proteins: signaling dynamics to disease management
- NADPH oxidase family proteins: signaling dynamics to disease management
- NADPH oxidase family proteins: signaling dynamics to disease management
- NADPH oxidase family proteins: signaling dynamics to disease management
- NADPH oxidase family proteins: signaling dynamics to disease management
- Predicting oncology drug-induced cardiotoxicity with donor-specific iPSC-CMs—a proof-of-concept study with doxorubicin
- Predicting oncology drug-induced cardiotoxicity with donor-specific iPSC-CMs—a proof-of-concept study with doxorubicin
- Predicting oncology drug-induced cardiotoxicity with donor-specific iPSC-CMs—a proof-of-concept study with doxorubicin
- Predicting oncology drug-induced cardiotoxicity with donor-specific iPSC-CMs—a proof-of-concept study with doxorubicin
Similar Researchers
Based on overlapping research topics